Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2000
11/30/2000WO2000071106A2 Method of treating weight gain
11/30/2000WO2000071101A2 Methods and compounds for inhibiting amyloid deposits
11/30/2000WO2000071097A1 Composition containing ascorbic acid salt
11/30/2000WO2000047735A3 NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/30/2000WO2000029846A3 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000DE10016771A1 Nutritional supplements containing flavonoid and catechin derivatives
11/30/2000CA2684016A1 Methods and compounds for inhibiting amyloid deposits
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374668A1 New pharmaceutical combinations for nos inhibitors
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374225A1 Naphthalene ureas as glucose uptake enhancers
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2363784A1 Method of treatment
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1055372A2 A method of treating colostrum
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054993A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054881A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054669A2 Use of thiadiazolo[4,3-a]pyridine derivatives
11/29/2000EP1054665A2 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia
11/29/2000EP1054595A1 Methods and compounds for the genetic treatment of hyperlipidemia
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000EP1001788A4 Boron carbohydrate complexes and uses thereof
11/29/2000EP0586592B1 Insulin and amylin containing composition for the treatment of insulin deficient mammals
11/29/2000CN1275132A Treatmet of obesity
11/29/2000CN1275082A Solid oral dosage form comprising combination of metformin and glibenclamide
11/29/2000CN1275055A Food supplement composition based on dehydrated crab meat
11/29/2000CN1274719A Process for preparation of substituted pyridine compound
11/29/2000CN1274580A Stable delayed vitamin C preparation and its production process
11/29/2000CN1274579A Method for producing particle with hepatoflavin
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153625 For treatment of disorders in which involvement of serotoninergic system has been demonstrated, as in psychiartic disorders such as depression, anxiety, panic attack, schizophrenia, aggression, impulsive disorders
11/28/2000US6153622 Estrogen agonists/antagonists
11/28/2000US6153605 Useful in treatment or prevention of vitamin d dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure
11/28/2000US6153604 Treating disease of nervous system in which pathophysiology of disorder involves excessive excitation of nerve cells by agonists of nmda receptors, comprising administering to guanidine derivative
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis
11/28/2000US6153242 Method for preparing snack food
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/28/2000CA2172149C Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
11/28/2000CA2085037C Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor compound
11/25/2000CA2309226A1 A method of treating colostrum
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000069911A1 Long lasting insulinotropic peptides
11/23/2000WO2000069901A2 Proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000069510A1 Energized trace elements
11/23/2000WO2000069470A2 Improved cellular uptake of bioactive agents
11/23/2000WO2000069430A1 Novel diphenylethylene compounds
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO2000043371A3 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000043354A3 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000021486A9 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid
11/23/2000WO2000015790A3 Leptin induced genes
11/23/2000WO2000012740A3 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
11/23/2000WO2000009666A3 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
11/23/2000WO1999061398A3 24-hydroxyvitamin d, analogs and uses thereof
11/23/2000DE19922462A1 New phenylureidobenzyl-substituted spiro-imidazolidinedione derivatives, are inhibitors of leukocyte adhesion or migration or VLA-4 receptors, useful e.g. for treating inflammatory or allergic disease
11/23/2000CA2501421A1 Long lasting exendin-4
11/23/2000CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/23/2000CA2373681A1 Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
11/23/2000CA2373603A1 Novel diphenylethylene compounds
11/23/2000CA2373532A1 Morpholino-n-ethyl ester derivative of an indole spla2 inhibitor
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372393A1 Novel proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000CA2370066A1 Thiazolopyrimidines useful as tnf.alpha. inhibitors
11/23/2000CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/22/2000EP1054012A1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes
1 ... 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 ... 1298